The Management of Chemotherapy-Induced Nausea and Vomiting
- 1 March 1987
- journal article
- review article
- Published by Elsevier in Medical Clinics of North America
- Vol. 71 (2) , 289-301
- https://doi.org/10.1016/s0025-7125(16)30871-9
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Antiemetic effect of oral versus intravenous metoclopramide in patients receiving cisplatin: a randomized, double-blind trial.Journal of Clinical Oncology, 1986
- Metoclopramide: dose-related toxicity and preliminary antiemetic studies in children receiving cancer chemotherapy.Journal of Clinical Oncology, 1985
- A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.Journal of Clinical Oncology, 1985
- Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.BMJ, 1984
- Neuropharmacology of Chemotherapy-induced EmesisDrugs, 1983
- High-dose dexamethasone for prevention of cis-platin-induced vomitingCancer Chemotherapy and Pharmacology, 1981
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Delta-9-Tetrahydrocannabinol as an Antiemetic for Patients Receiving Cancer ChemotherapyAnnals of Internal Medicine, 1979
- Delta-9-Tetrahydrocannabinol as an Antiemetic in Cancer Patients Receiving High-Dose MethotrexateAnnals of Internal Medicine, 1979
- Droperidol Prevents Nausea and Vomiting fromcis-PlatinumNew England Journal of Medicine, 1979